News
-
-
-
-
-
-
PRESS RELEASE
PARMANTIER & CIE. is starting coverage of CLINUVEL Pharmaceuticals Ltd.
PARMANTIER & CIE. initiates coverage of CLINUVEL Pharmaceuticals Ltd., a leader in melanocortin-based therapies for skin disorders and cancer prevention. Includes SCENESSE® for rare disease EPP and nutraceuticals division for skin health improvement -
-
-
-